Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction ; day:23 ; month:4 ; year:2022 ; pages:1-18
Cancer immunology immunotherapy ; (23.4.2022), 1-18
- Urheber
-
Zangari, Brendan
Tsuji, Takemasa
Matsuzaki, Junko
Mohammadpour, Hemn
Eppolito, Cheryl
Battaglia, Sebastiano
Ito, Fumito
Chodon, Thinle
Koya, Richard
Robert McGray, A. J.
Odunsi, Kunle
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-022-03197-2
- URN
-
urn:nbn:de:101:1-2022080323101199217195
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zangari, Brendan
- Tsuji, Takemasa
- Matsuzaki, Junko
- Mohammadpour, Hemn
- Eppolito, Cheryl
- Battaglia, Sebastiano
- Ito, Fumito
- Chodon, Thinle
- Koya, Richard
- Robert McGray, A. J.
- Odunsi, Kunle
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8+ T‑cells from GzmB mediated self‑destruction
Development of a novel TCR avidity assay for human CD8+ T-cells
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature T-cells
Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
Correction to: Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness
Differential antigen dependency of CD4 + and CD8 + T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
System analysis of TCR and IFN signaling in CD8+ cells
Immunregulatorische Funktion humaner TCRαβ+-CD4--CD8--T-Lymphozyten [TCR-alpha-beta+ CD4- CD8- T-Lymphozyten]
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8+ T‑cells from GzmB mediated self‑destruction
Development of a novel TCR avidity assay for human CD8+ T-cells
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature T-cells
Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
Correction to: Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness
Differential antigen dependency of CD4 + and CD8 + T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
System analysis of TCR and IFN signaling in CD8+ cells
Immunregulatorische Funktion humaner TCRαβ+-CD4--CD8--T-Lymphozyten [TCR-alpha-beta+ CD4- CD8- T-Lymphozyten]
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8+ T‑cells from GzmB mediated self‑destruction
Development of a novel TCR avidity assay for human CD8+ T-cells
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature T-cells
Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
Correction to: Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness
Differential antigen dependency of CD4 + and CD8 + T-cells
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
System analysis of TCR and IFN signaling in CD8+ cells
Immunregulatorische Funktion humaner TCRαβ+-CD4--CD8--T-Lymphozyten [TCR-alpha-beta+ CD4- CD8- T-Lymphozyten]